HOUSTON, July 28, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
This article was originally featured on Knowable Magazine. Roughly 20 years ago, a biologist named Caroline Gargett went in search of some remarkable cells in tissue that had been removed during ...
The sea anemone Nematostella vectensis is potentially immortal. Using molecular genetic methods, developmental biologists led by Ulrich Technau from the University of Vienna have now identified ...
The sea anemone Nematostella vectensis is potentially immortal. Using molecular genetic methods, developmental biologists have now identified possible candidates for multipotent stem cells in the sea ...
Researchers from the University of Vienna have identified potential candidates for multipotent stem cells in the sea anemone for the first time. These stem cells are regulated by evolutionary highly ...
MSCs improve therapeutic consistency and precision across cell therapies. The approach also supports scalable allogeneic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results